LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.79 | 27.76 | 30 | 1605 | 0.0187 | 0.0134 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.79 | 27.76 | 895 | 1605 | 0.5576 | 0.8101 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.49 | 27.76 | 6 | 1723 | 0.0035 | -0.2268 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.49 | 27.76 | 621 | 1723 | 0.3604 | 0.6851 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.49 | 27.76 | 25 | 1723 | 0.0145 | -0.0174 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.49 | 27.76 | 892 | 1723 | 0.5177 | 0.7907 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.19 | 27.76 | 10 | 1863 | 0.0054 | -0.1548 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.19 | 27.76 | 619 | 1863 | 0.3322 | 0.6679 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.19 | 27.76 | 28 | 1863 | 0.0150 | 0.0014 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.19 | 27.76 | 886 | 1863 | 0.4755 | 0.7694 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.90 | 27.76 | 21 | 2032 | 0.0103 | -0.0440 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.90 | 27.76 | 626 | 2032 | 0.3080 | 0.6537 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.90 | 27.76 | 27 | 2032 | 0.0133 | -0.0045 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.90 | 27.76 | 889 | 2032 | 0.4374 | 0.7501 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.60 | 27.76 | 35 | 2235 | 0.0157 | 0.0373 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.60 | 27.76 | 624 | 2235 | 0.2791 | 0.6349 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.60 | 27.76 | 30 | 2235 | 0.0134 | 0.0123 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.60 | 27.76 | 901 | 2235 | 0.4030 | 0.7326 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.30 | 27.76 | 48 | 2449 | 0.0196 | 0.0884 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.30 | 27.76 | 629 | 2449 | 0.2568 | 0.6206 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.30 | 27.76 | 25 | 2449 | 0.0102 | -0.0161 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.30 | 27.76 | 891 | 2449 | 0.3637 | 0.7103 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.01 | 27.76 | 59 | 2662 | 0.0222 | 0.1213 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.01 | 27.76 | 628 | 2662 | 0.2358 | 0.6060 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.01 | 27.76 | 30 | 2662 | 0.0113 | 0.0119 | MN20160318_Q01 | K20 |